NO930244L - Umettede 17beta-substituerte 3-karboksysteroider - Google Patents

Umettede 17beta-substituerte 3-karboksysteroider

Info

Publication number: NO930244L
Authority: NO; Norway
Prior art keywords: group; hydrogen; cycloalkyl; alkyl group; alkyl
Prior art date: 1991-05-24

Application number

NO93930244A

Other languages

English (en)

Norwegian (no)

Other versions

NO930244D0 (no

Inventor

Achille Panzeri

Marcella Nesi

Enrico Di Salle

Original Assignee

Erba Carlo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-24

Filing date

1993-01-25

Publication date

1993-01-27

1993-01-25 Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa

1993-01-25 Publication of NO930244D0 publication Critical patent/NO930244D0/no

1993-01-27 Publication of NO930244L publication Critical patent/NO930244L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Dental Preparations (AREA)
Details Of Garments (AREA)
Ceramic Products (AREA)
Medicines Containing Plant Substances (AREA)

NO93930244A 1991-05-24 1993-01-25 Umettede 17beta-substituerte 3-karboksysteroider NO930244L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ITMI911432A IT1259419B (it)	1991-05-24	1991-05-24	Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
PCT/EP1992/001153 WO1992020700A1 (en)	1991-05-24	1992-05-22	UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS

Publications (2)

Publication Number	Publication Date
NO930244D0 NO930244D0 (no)	1993-01-25
NO930244L true NO930244L (no)	1993-01-27

Family

ID=11359980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO93930244A NO930244L (no)	1991-05-24	1993-01-25	Umettede 17beta-substituerte 3-karboksysteroider

Country Status (26)

Country	Link
US (1)	US5212166A (id)
EP (2)	EP0540717B1 (id)
JP (1)	JP3226919B2 (id)
CN (1)	CN1035055C (id)
AT (1)	ATE155792T1 (id)
AU (1)	AU655280B2 (id)
CA (1)	CA2087953A1 (id)
CZ (1)	CZ281309B6 (id)
DE (1)	DE69221074T2 (id)
DK (1)	DK0540717T3 (id)
ES (1)	ES2106185T3 (id)
FI (1)	FI930277A7 (id)
HU (1)	HUT64083A (id)
ID (1)	ID954B (id)
IE (1)	IE921634A1 (id)
IL (1)	IL101947A (id)
IT (1)	IT1259419B (id)
MX (1)	MX9202438A (id)
MY (1)	MY131089A (id)
NO (1)	NO930244L (id)
NZ (1)	NZ242850A (id)
RU (1)	RU2104283C1 (id)
TW (1)	TW213467B (id)
WO (1)	WO1992020700A1 (id)
YU (1)	YU52992A (id)
ZA (1)	ZA923758B (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5618806A (en) *	1992-04-30	1997-04-08	Smithkline Beecham Corporation	17α and 17β-substituted estra-1,3,5(10)-triene-3-carbboxlic acid
US5683995A (en) *	1992-11-18	1997-11-04	Smithkline Beecham Corporation	17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5641765A (en) *	1992-11-18	1997-06-24	Smithkline Beecham Corporation	17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
EP0717618B1 (en) *	1993-09-03	2002-11-06	Smithkline Beecham Corporation	Stabilized tablet formulation
GB9324371D0 (en) *	1993-11-26	1994-01-12	Erba Carlo Spa	Side chain fluoro substituted 3-carboxysteroids
US5430157A (en) *	1993-12-13	1995-07-04	Eli Lilly And Company	Reduced phenanthrenes
GB9402041D0 (en) *	1994-02-03	1994-03-30	Smithkline Beecham Corp	Compounds
US5714480A (en) *	1994-03-31	1998-02-03	Smithkline Beecham Corporation	Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
WO1995028413A1 (en) *	1994-04-15	1995-10-26	Smithkline Beecham Corporation	17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
GB9415183D0 (en) *	1994-07-28	1994-09-21	Erba Carlo Spa	3-carboxysteroids with a fluorinated side-chain
US5543417A (en) *	1994-10-21	1996-08-06	Merck & Co., Inc.	Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
ATE473759T1 (de)	1998-05-22	2010-07-15	Univ Leland Stanford Junior	Bifunktionelle moleküle sowie darauf basierende therapien.
HUP0203045A3 (en) *	1999-09-22	2004-06-28	Sanofi Aventis Deutschland	4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
EP2392258B1 (en)	2005-04-28	2014-10-08	Proteus Digital Health, Inc.	Pharma-informatics system
US9062126B2 (en)	2005-09-16	2015-06-23	Raptor Pharmaceuticals Inc.	Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
PL3395372T3 (pl)	2009-02-20	2022-07-25	EnhanX Biopharm Inc.	Układ do dostarczania leków na bazie glutationu
CN102458374A (zh)	2009-05-06	2012-05-16	实验室护肤股份有限公司	包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4377584A (en) *	1978-04-13	1983-03-22	Merck & Co., Inc.	4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US5041433A (en) *	1987-04-29	1991-08-20	Smithkline Beecham Corporation	11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US4910226A (en) *	1987-04-29	1990-03-20	Smithkline Beckman Corporation	Steroid 5-alpha-reductase inhibitors
US5032586A (en) *	1989-08-24	1991-07-16	Smithkline Beecham Corporation	7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5091380A (en) *	1990-06-28	1992-02-25	Merck & Co., Inc.	N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
DK0567271T3 (da) *	1992-04-20	1998-02-16	Sankyo Co	Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf

1991
- 1991-05-24 IT ITMI911432A patent/IT1259419B/it active IP Right Grant
1992
- 1992-05-20 MY MYPI92000863A patent/MY131089A/en unknown
- 1992-05-20 YU YU52992A patent/YU52992A/sh unknown
- 1992-05-21 IL IL10194792A patent/IL101947A/en active IP Right Grant
- 1992-05-21 NZ NZ242850A patent/NZ242850A/en unknown
- 1992-05-21 US US07/886,574 patent/US5212166A/en not_active Expired - Lifetime
- 1992-05-22 DE DE69221074T patent/DE69221074T2/de not_active Expired - Fee Related
- 1992-05-22 EP EP92910992A patent/EP0540717B1/en not_active Expired - Lifetime
- 1992-05-22 HU HU9300176A patent/HUT64083A/hu unknown
- 1992-05-22 JP JP50978992A patent/JP3226919B2/ja not_active Expired - Fee Related
- 1992-05-22 ID IDP308292A patent/ID954B/id unknown
- 1992-05-22 EP EP92108670A patent/EP0517047A1/en active Pending
- 1992-05-22 CZ CZ93265A patent/CZ281309B6/cs unknown
- 1992-05-22 WO PCT/EP1992/001153 patent/WO1992020700A1/en not_active Ceased
- 1992-05-22 ES ES92910992T patent/ES2106185T3/es not_active Expired - Lifetime
- 1992-05-22 MX MX9202438A patent/MX9202438A/es unknown
- 1992-05-22 TW TW081104019A patent/TW213467B/zh active
- 1992-05-22 DK DK92910992.4T patent/DK0540717T3/da active
- 1992-05-22 ZA ZA923758A patent/ZA923758B/xx unknown
- 1992-05-22 CA CA002087953A patent/CA2087953A1/en not_active Abandoned
- 1992-05-22 AT AT92910992T patent/ATE155792T1/de active
- 1992-05-22 RU RU93004939A patent/RU2104283C1/ru active
- 1992-05-22 AU AU17781/92A patent/AU655280B2/en not_active Ceased
- 1992-05-23 CN CN92103919A patent/CN1035055C/zh not_active Expired - Fee Related
- 1992-07-01 IE IE163492A patent/IE921634A1/en unknown
1993
- 1993-01-25 NO NO93930244A patent/NO930244L/no unknown
- 1993-05-22 FI FI930277A patent/FI930277A7/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
RU2104283C1 (ru)	1998-02-10
CZ26593A3 (en)	1993-11-17
HUT64083A (en)	1993-11-29
IL101947A (en)	1996-01-19
EP0540717A1 (en)	1993-05-12
JPH06500342A (ja)	1994-01-13
MY131089A (en)	2007-07-31
WO1992020700A1 (en)	1992-11-26
DE69221074T2 (de)	1997-11-13
HU9300176D0 (en)	1993-04-28
IE921634A1 (en)	1992-12-02
CN1035055C (zh)	1997-06-04
ZA923758B (en)	1993-01-27
MX9202438A (es)	1992-11-01
NO930244D0 (no)	1993-01-25
TW213467B (id)	1993-09-21
US5212166A (en)	1993-05-18
CN1067057A (zh)	1992-12-16
ID954B (id)	1996-09-25
ITMI911432A0 (it)	1991-05-24
FI930277A0 (fi)	1993-01-22
ITMI911432A1 (it)	1992-11-24
CA2087953A1 (en)	1992-11-25
EP0517047A1 (en)	1992-12-09
ES2106185T3 (es)	1997-11-01
AU655280B2 (en)	1994-12-15
ATE155792T1 (de)	1997-08-15
JP3226919B2 (ja)	2001-11-12
EP0540717B1 (en)	1997-07-23
FI930277A7 (fi)	1993-01-22
YU52992A (sh)	1995-03-27
DK0540717T3 (da)	1997-08-18
DE69221074D1 (de)	1997-09-04
NZ242850A (en)	1994-01-26
IT1259419B (it)	1996-03-18
CZ281309B6 (cs)	1996-08-14
AU1778192A (en)	1992-12-30

Publication	Publication Date	Title
NO930244L (no)	1993-01-27	Umettede 17beta-substituerte 3-karboksysteroider
NO913923L (no)	1991-12-06	17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse
NO20091012L (no)	2009-03-26	Kinazolinon- og isokinolinonacetamid derivater
DK0623140T3 (da)	1999-02-15	Nye 19-nor steroider med en svovlcarbonkæde i 11-beta stilling, fremgangsmåde til deres fremstilling og mellemstofferne der
NO860973L (no)	1986-09-17	Hydroksamsyrearylderivater og fremgangsmaate for deres fremstilling.
WO2004060865A3 (en)	2004-11-04	N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
NO20031701L (no)	2003-05-23	Fremgangsmåte og mellomprodukter i fremstilling av 7- substituerte antiöstrogener
NO944926L (no)	1995-06-22	Fremgangsmåter for å inhibere myeloperoksidaseaktivitet
NO972951L (no)	1997-12-29	Stabilisatorer for pulverlakker
FI914504A0 (fi)	1991-09-25	Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DE69200284D1 (de)	1994-09-08	Verwendung von 4-(3-trifluormethylphenyl)-1,2,3,6-Tetrahydropyridinderivaten als freie Radikalfänger.
ES402755A1 (es)	1975-04-01	Procedimiento para la preparacion de 5-nitro-pirimidinas.
ES2027357T3 (es)	1992-06-01	Una composicion herbicida y su procedimiento de preparacion.
ES483214A1 (es)	1980-09-01	Un procedimiento para la preparacion de compuestos derivadosde morfolina y piperidina
NO951072L (no)	1995-09-25	Polyjoderte forbindelser, fremgangsmåte for deres fremstilling og diagnostisk preparat
NO961537L (no)	1996-10-21	Salpetersyreestere fra derivater av 2-(2,6-dihalofenylamino)-fenylacetoksyeddiksyre, og deres fremstillingsprosedyrer
ATE316953T1 (de)	2006-02-15	Stabilisator für hydroxylaminlösungen
DK564788D0 (da)	1988-10-10	2-azetidinon-derivater
DK2078723T3 (da)	2011-03-28	Fremgangsmåde til syntese af organo-oxazaborolidiner
DE502004009401D1 (de)	2009-06-04	18-gliedrige nitrobenzyl- und aminobenzyl-substituierte cyclohexadepsipeptide zur bekämpfung von endoparasiten und ein verfahren zu ihrer herstellung
ES269194A3 (es)	1962-01-01	Procedimiento de obtencion de ésteres fosforicos
ES247667A1 (es)	1959-12-16	Procedimiento para la preparacion de nuevas sulfamil-benzamidas
ES362073A3 (es)	1970-11-01	Un metodo para producir compuestos que disminuyen el coles-terol.
ES255574A1 (es)	1960-04-16	Procedimiento para la elaboracion de nuevas piperidonas-(4), 1, 2, 6 sustituidas o de sus sales
ES395980A2 (es)	1973-12-16	Procedimiento para la obtencion de derivados basicamente sustituidos de la 2,4-(1h,3h)-quinazolidiona.